[Acute endophthalmitis of 15-year old boy in the course of acute lymphoblastic leukemia--part I].
OBJECTIVE
The aim of this study is to present dramatic ocular manifestation of acute lymphoblastic leukemia.


METHODS
15-year old boy was hospitalized due to acute leukemia at the Department and Clinic of Pediatric Hematology and was referred to ophthalmologist because of strong pain and decreased visual acuity of the left eye. General ophthalmic examination and electrophysiology were done. These procedures were repeated after 1, 2, 5 and 11 weeks and also after 6 and 9 months.


RESULTS
Acute uveitis with cellular exudation to the vitreous, papilledema, swelling of the macula and green-yellowish infiltration which elevated the temporal part of the retina, were noticed. Swelling of the iris and miosis were observed. After one week of local anti-inflammatory treatment the eye became painless with little deep injection only. Simultaneously causal treatment of basic disease was continued. Control examinations revealed step by step improvement of ocular changes. After 6 months in the place of retinal infiltration choroidoretinal atrophy was seen. The functional deficits in visual field and electrophysiological examinations were found, too. One year later, the patient came again because of recurrence. Involvement of the central nervous system with signs of meningitis occurred. Visual acuity was normal and no infiltration of eyes was found, but there was papilledema in both eyes.


CONCLUSIONS
In acute leukemia ocular manifestation may be highly expressed. The patients require local symptomatic and general causal treatment in cooperation of ophthalmologist with hematologist.
Pojda-Wilczek
Dorota
D
Oddziału Klinicznego Okulistyki Slaskiej Akademii Medycznej w Katowicach.
Pojda
Stefan M
SM
Zatorska
Barbara
B
Herba
Ewa
E
Jedrzejewski
Wojciech
W
Janik-Moszant
Anna
A
Bubała
Halina
H
D000208:Acute Disease; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D009877:Endophthalmitis / Q000209:etiology*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy*